EFGCP-DIA Paediatric Conference
Date: 28 / 09 / 2010 - 29 / 09 / 2010
Location: London, UK
Description:
The EFGCP Children’s Medicines Working Party and DIA Europe are pleased to invite you to take part to their second joint paediatric conference. Traditional paediatric meetings of both societies in the past and the joint meeting in 2009 have attracted top level speakers from the European Medicines Agency (EMA), Food and Drug Administration (FDA), national authorities, World Health Organization (WHO), academia, pharmaceutical industry and parents & patients’ organizations. This second joint program will again offer the opportunity for intensive discussion among stakeholders in different topics relevant for pediatric medicines. We will address visions, daily challenges and ways forward in paediatric drug development. On this basis, the conference will also offer excellent networking opportunities for all attendees.
The conference will include three parallel breakout sessions on each day for a lively interactive discussion. Furthermore, it will provide participants with the opportunity of asking questions by e-mail before the conference and during the morning of day 1, which will be in the afternoon addressed by a speaker panel chaired by Paolo Tomasi, EMA.
Conference objectives
- Update participants how to deal with paediatric regulatory requirements, scientific and operational challenges
- Exchange experiences with regulatory authorities, academia and industry
- Discuss visions, daily challenges and potential ways to move forward and further improve processes for paediatric drug development
Who should attend?
- Regulatory, clinical and drug development professionals from Health Authorities and Industry
- Pediatricians, Representatives from Academia, Paediatric Societies and Networks
- Employees from Clinical Research Organisations (CROs) involved in paediatric clinical trials
- Any stakeholder interested in the development of better medicines for children
Session overview
- Challenges of the EU paediatric regulation as perceived by industry
- Strengths and weaknesses of academic European paediatric research
- Operational challenges for paediatric trials and how to overcome them
- Special challenges in neonatal research
- Common features of rare conditions and the way forward: Pediatric Oncology & Rheumatology
- Funding for paediatric research
- Small & Medium Enterprises and paediatric drug development
- Media, parents & clinical research: challenges & opportunities
- Speakers panel discussion: participants addressing/clarifying issues and seeking advice
More information: http://www.efgcp.be/Conference_details.asp?id=269&L1=10&L2=1&TimeRef=1
Email address: CONFERENCES@EFGCP.BE